Filing Details
- Accession Number:
- 0001209191-19-043395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-26 17:26:30
- Reporting Period:
- 2019-06-13
- Accepted Time:
- 2019-07-26 17:26:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-13 | 60 | $6.42 | 11,618 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-14 | 60 | $6.37 | 11,678 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-17 | 60 | $6.33 | 11,738 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-18 | 60 | $6.36 | 11,798 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-19 | 60 | $6.35 | 11,858 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-20 | 60 | $6.33 | 11,918 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-21 | 60 | $6.34 | 11,978 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-24 | 60 | $6.54 | 12,038 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-25 | 60 | $6.56 | 12,098 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-26 | 60 | $6.54 | 12,158 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 60 | $6.48 | 12,218 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-28 | 60 | $6.49 | 12,278 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 60 | $6.52 | 12,338 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-02 | 60 | $6.49 | 12,398 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-03 | 60 | $6.46 | 12,458 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-05 | 60 | $6.49 | 12,518 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-08 | 60 | $6.37 | 12,578 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-09 | 60 | $6.15 | 12,638 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 60 | $6.07 | 12,698 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-11 | 60 | $5.93 | 12,758 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-12 | 60 | $6.01 | 12,818 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-15 | 60 | $5.85 | 12,878 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-16 | 60 | $5.88 | 12,938 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-17 | 60 | $5.85 | 12,998 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-18 | 60 | $5.84 | 13,058 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-19 | 60 | $5.69 | 13,118 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-22 | 60 | $5.75 | 13,178 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-24 | 60 | $5.93 | 13,238 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.